OKYO Stock Analysis: Buy, Sell, or Hold?
OKYO - OKYO Pharma Limited Ordinary Shares
$1.46
-0.01 (-0.68%)
âŧ
5d:
+6.57%
30d:
-5.81%
90d:
-16.57%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Jul 17, 2026
0d
Get Alerted When OKYO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: OKYO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: OKYO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: OKYO is currently trading at $1.46, which is considered fair relative to its 30-day fair value range of $1.33 to $1.53.
Technical Outlook: Technically, OKYO is in a downtrend. The price is approaching resistance at $1.47. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $8.33 (+466.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OKYO is in a downtrend. The price is approaching resistance at $1.47. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $8.33 (+466.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.33 -
$1.53
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (54/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 466.9% below Wall St target ($8.33)
- WARNING: Composite score 47/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.33 -
$1.53
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.26
Resistance Level
$1.47
Current Trend
Downtrend
Technical data as of
Oct 5, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.35
Wall Street Target
$8.33
(+466.9%)
Share & Embed Analysis
Last updated: October 05, 2026 3:38 PM ET
Data refreshes hourly during market hours. Next update: 4:38 PM
Data refreshes hourly during market hours. Next update: 4:38 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OKYO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$109 | 82 BUY |
|
BMRN
Biomarin Pharmaceutical âĻ |
STRONG BUY
27 analysts |
$92 | 52 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$285 | 40 SELL |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
17 analysts |
$37 | 60 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
19 analysts |
$18 | 53 HOLD |
